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Abstract
National attention to the effects of interpersonal trauma has led mental health systems to adopt
policies on trauma-related services; however, there is a lack of clarity regarding targeting of these
services. Data from the Women, Co-occurring Disorders and Violence Study (WCDVS) were
reanalyzed by grouping women on their baseline PTSD and substance abuse presentation and
assessing the differential response to an integrated mental health/substance abuse intervention.
Treatment effects were largest for subgroups characterized by high levels of PTSD, whereas the
effects for those in the low symptom group were near zero. These findings underscore the need for
clinicians to conduct careful assessments of trauma-related symptoms and to target the most intensive
trauma-related interventions to individuals with PTSD symptoms.
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Interpersonal trauma such as physical or sexual abuse is a serious and common public health
issue, as highlighted in the U.S. Surgeon General’s report on mental health (United States
Department of Health and Human Services [DHHS] 1999). Indeed, epidemiological studies
indicate that 38–59% of the U.S. population has experienced some form of interpersonal trauma
(Breslau et al. 1998; Kessler et al. 1995; Tjaden and Thoennes 2000). Among women with
serious mental illness (SMI) seeking services, lifetime rates of exposure to interpersonal
violence are much higher, with estimates ranging between 43% and 97% (Carmen et al.
1984; Cascardi et al. 1996; Goodman et al. 1995). Data also suggest that women are at greater
risk than men for more serious and/or chronic forms of victimization (e.g., sexual assault,
domestic violence) (Pimlott-Kubiak and Cortina 2003).
A wealth of research demonstrates the pervasive negative consequences of interpersonal
trauma (Kessler et al. 1995; Breslau et al. 2000; Kilpatrick et al. 1998). These outcomes include
posttraumatic stress disorder (PTSD), substance abuse, somatic complaints, and general
psychological distress. Among women with SMI, sexual and physical abuse are related to more
severe symptoms of mental illness such as psychotic symptoms, depression, suicidality, anxiety
and dissociation (Carmen et al. 1984; Beck and van der Kolk 1987; Briere et al. 1997; Craine
et al. 1988; Muenzenmaier et al. 1993; Surrey et al. 1990). Studies have also found the
experience of trauma to be related to greater use of high cost, acute care services (Carmen et
al. 1984; Briere et al. 1997; Elhai et al. 2005).
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Following depression, substance abuse is the second most common disorder co-occurring with
PTSD for women (Kessler et al. 1995; Jacobsen et al. 2001). A number of causal explanations
exist which posit a central role for PTSD in the relationship between trauma and substance
abuse (Chilcoat and Breslau 1998; Mueser et al. 2002). Studies indicate that the comorbidity
of substance abuse with PTSD is associated with more severe PTSD symptoms, significantly
higher rates of other comorbid Axis I and II disorders, psychosocial and medical problems,
inpatient hospital admissions, and relapse compared to substance abuse patients without
comorbid PTSD (Jacobsen et al. 2001).
Expert opinion combined with research over the past 10 years (including emerging research
on the simultaneous treatment of PTSD and substance abuse) indicates that treatment outcomes
are best when mental health and substance abuse disorders are treated simultaneously (Brady
et al. 2004; Drake and Mueser 2001; Najavits et al. 1997). However, services for people with
mental illness and substance abuse are often fragmented, and these individuals often end up
being bounced back and forth between service systems (Mueser et al. 2003). Furthermore, few
individuals receive appropriate PTSD related services, as trauma history tends not to be
assessed and PTSD is often overlooked as a result (Cusack et al. 2006; Mueser et al. 1998). In
recent years, greater national attention to this issue, including position statements from the
National Association of State Mental Health Program Directors (NASMHPD) and the National
Association of Consumer/Survivor Mental Health Administrators (NAC/SMA), has led to
increased efforts to incorporate trauma services into all aspects of mental health and substance
abuse services, including the formation of statewide Trauma Initiatives (e.g., Maine,
Connecticut, South Carolina) (Frueh et al. 2001) and national-level groups focused on raising
awareness about the prevalence of trauma and promoting effective, integrated, trauma-
informed, and trauma-specific services (e.g., the National Trauma Consortium;
http://www.nationaltraumaconsortium.org).
Despite these efforts, clear guidelines regarding the appropriate targeting of trauma-related
interventions do not exist. While most trauma experts emphasize PTSD symptoms as the
appropriate target (Foa et al. 2000), others have argued for a much broader view of trauma
sequelae, and consequently, a much wider range of symptoms targeted for trauma-related
intervention. (Fallot and Harris 2002). As a result, state mental health systems use widely
varying definitions of target populations for trauma-related services, ranging from individuals
with a history of abuse to those presenting with PTSD (Jennings 2004).
The question of how to target trauma-related services can be assessed empirically by an
intervention study with a large, regionally diverse sample of individuals with trauma histories.
The Women, Co-occurring Disorders and Violence Study (WCDVS) provides the best
available data in these regards. WCDVS was a federally-funded, multi-site quasi-experimental
evaluation of integrated services for women with co-occurring mental illness and substance
abuse who were victims of trauma. The study was conducted from 1998 to 2003 across nine
sites in the United States. This study was the largest to date (N = 2,729) to evaluate services
for women with complex presentations of trauma history, mental health and substance abuse
needs (for full description see McHugo et al. 2005b; Morrissey et al. 2005a).
The primary analysis of 6-month and 12-month outcomes of the WCDVS revealed small yet
positive overall effects of the intervention relative to a comparison treatment-as-usual on
general mental health, PTSD symptoms, and substance abuse severity at 6 months (Morrissey
et al. 2005a, b; Cocozza et al. 2005). However, the inclusion criteria of the WCDVS stipulated
only that the women have a history of interpersonal trauma and comorbid mental health and
substance abuse disorders of any type. As a consequence, sites had some leeway in who was
enrolled and the resultant sample of 2,729 women represented a wide range of lifetime
traumatic experiences, PTSD severity, and substance abuse problems (Becker et al. 2005).
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The main analyses of WCDVS outcomes employed an experimental logic and focused on
average effects for the overall sample that was followed-up at 6 and 12 months. In contrast,
the present study disaggregates the sample and asks whether outcomes varied for several
empirically-derived subgroups of women who had different symptom presentations prior to
study enrollment. Consistent with the existing trauma literature, we expected considerable
variation in the type and degree of trauma-related comorbidity in this sample. Further, we
expected that these subgroups of women would have distinct profiles across mental and
physical health indicators.
Specifically, we expected subgroups with higher levels of PTSD symptom severity at baseline
would have higher rates of both child and adult abuse and would report a greater lifetime
frequency of traumatic events. We also expected that subgroups with high levels of PTSD
severity at baseline would demonstrate worse mental health functioning in additional areas
(e.g., psychosis, paranoia, general mental health), earlier onset of mental health problems, and
worse physical health. Finally, we expected women with active high levels of PTSD to have
a greater treatment response to the integrated intervention on measures of PTSD, general mental
health, and substance abuse (when indicated) than women with other symptom characteristics.
Methods
Study Design Overview
The WCDVS sought to determine whether integrated trauma care would lead to better
outcomes for women than receiving usual care in the form of separate and uncoordinated mental
health and substance abuse services. The study set out to recruit a population of women who
were difficult to treat and who were high utilizers of services (McHugo et al. 2005b). The
criteria specified that participants be age 18 or older, have a chart-documented DSM-IV Axis
I or II psychiatric disorder and a DSM-IV substance use disorder (at least one of which was
symptomatic in the past 30 days and the other in the past 5 years), have a history of physical
and/or sexual abuse, have two or more previous service episodes, and speak English or Spanish
as their primary language.
Trained interviewers administered the cross-site protocol to each participant. The protocol
assessed demographic characteristics, traumatic life events, mental health symptoms, and
substance use. Each intervention site provided services that were comprehensive, used one of
several trauma-specific intervention models in a group format (TREM, Seeking Safety, Atrium,
TRIAD; more details of the sites and interventions can be found in McHugo et al. 2005b),
integrated mental health and substance abuse services, and involved consumers in advisory
and service provision roles. In the absence of evidence that any one comprehensive, integrated,
trauma/substance abuse intervention was more effective, sites were encouraged to be creative
in adapting existing service models to their site. Each model was relatively brief, ranging from
12 to 33 sessions. Women recruited into the control condition received treatment-as-usual at
a local service setting comparable to the intervention site but without integrated trauma care.
Participants
The women were enrolled in the study through local projects in California (two sites),
Colorado, Florida, Massachusetts (three sites), New York City, and Washington, DC. The
average age was 36 years (range 18–76). The women were from diverse racial and ethnic
backgrounds (17% Hispanic, 50% White non-Hispanic, 25% Black non-Hispanic, 7% other
non-Hispanic). The median number of years of education was 12. About a third (38%) of the
sample was married or partnered (28% never married). Most (70%) had experienced
homelessness and half (51%) reported a current serious physical illness or disability. As a
group, the women reported long-term mental health, substance use, and trauma experiences as
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indicated by first mental health problem by age 12 (50%), regular use of alcohol to intoxication
for at least 5 years (50%), regular use of drugs for at least 10 years (50%), and childhood sexual
or physical abuse (79%).
Measures
Measures of PTSD symptoms and drug and alcohol use severity prior to study enrollment were
used to cluster the participants into subgroups. Drug use and alcohol use problem severity were
assessed using the Addiction Severity Index (ASI) (McLellan et al. 1980). The Drug Composite
Score (ASI-D) and Alcohol Composite Score (ASI-A) measure problem severity during the
prior 30 days. Possible scores range from 0 to 1, with higher scores indicating greater substance
use problem severity. The ASI-A score was modified slightly in consultation with its author,
but was scored on the original scale (for details, see McHugo et al. 2005b). At baseline, average
scores for the total sample were .20 on the ASI-D and .16 on the ASI-A, indicating a moderate
level of severity. Among women reporting any use, the mean scores were .23 and .38
respectively.
PTSD symptoms were assessed by the PTSD Symptom Scale (PSS) of the Post-traumatic Stress
Diagnostic Scale (Foa et al. 1993). This 17-item scale asks respondents to indicate how often
in the past month (on a scale of 0 [not at all or only once] to 3 [5 or more times or almost
always]) they experienced a list of problems sometimes experienced after a traumatic event.
Possible scores range from 0 to 51, with higher scores indicating more severe PTSD symptoms.
The PSS has high internal consistency and test–retest reliability and is highly correlated with
structured diagnostic interviews (Foa et al.). At baseline the average score for the total sample
was 23.7, indicating a moderate-to-severe level of symptom severity. For women who reported
any PTSD symptoms, the average score was 24.3.
In addition, the subgroups of women at baseline were profiled with three additional sets of
variables—demographic characteristics, trauma history, and mental health symptoms—in
order to test hypotheses related to the subgroups. Demographic variables were recorded at
baseline including age, race, education, employment, and homeless status.
Traumatic Events History was assessed with a version of the LSC-R (Wolfe and Kimerling
1997) that was modified for the WCDVS (McHugo et al. 2005a). The LSC-R is a 30-item
instrument that uses behaviorally specific language and includes probes to assess age at the
time of the first event and chronicity. The LSC-R has demonstrated good criterion-related
validity for PTSD in diverse populations of women and in several languages. Based on the
recommendations of the multidisciplinary WCDVS workgroup, the LSC-R was modified to
be more gender specific and culturally sensitive and to use greater caution in the wording of
questions related to abuse. The modified version of the LSC-R was found to have good test–
retest reliability (McHugo et al. 2005a).
Mental health symptoms were assessed using the Brief Symptom Inventory (BSI) (Derogatis
1993). The BSI is a 53-item self-report scale that measures nine symptom dimensions including
somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility,
phobic anxiety, paranoia, and psychoticism, and also includes a global severity index (GSI)
based on all nine symptom dimensions. Internal consistency and test–retest reliability range
from moderate to high for the various subscales. Respondents were asked how much a problem
distressed them in the past 7 days (ranging from 0 to 4, “not at all” to “extremely”). Possible
scores range from 0 to 4, with higher scores indicating more severe symptomatology. At
baseline, the average GSI raw score was 1.35 (T-score = 69) indicating a moderately elevated
level of symptom severity.
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Finally, the effects of the intervention were examined for PTSD symptoms (PSS), Substance
abuse (ASI-A, ASID), and global mental health problems (GSI).
Statistical Analyses
Analyses were performed in SPSS version 15.0 and in R version 1.9.1 (R Development Core
Team 2004). First, participants were grouped into empirically-derived clusters based on self-
reported symptoms on the PSS, ASI-alcohol, and ASI-drug measures. Baseline scores on the
three measures were standardized and then submitted to k-means cluster analysis (Hartigan
1975). The k-means approach was selected due to its ability to handle large samples and because
it is preferred in situations like the current study when the number of clusters in the data can
be inferred a priori from theory and extant literature (Hair et al. 1998). The technique uses an
algorithm to partition individual cases into a pre-specified number (k) of clusters, based on
their scores on the three measures, in a manner that maximizes between-cluster differences and
minimizes within-cluster variance. The cluster centers are iteratively updated until the optimal
groupings are achieved based on Euclidean distance. Based on expected profile combinations
of the presence or absence of PTSD, along with possible comorbid drug, alcohol, or neither
we requested six-, seven-, and eight-cluster solutions. The six-cluster solution was retained
based on overall fit of the data. We evaluated the validity of the resulting solution in two ways.
First, we examined the robustness of the solution by splitting the sample into two random
halves, conducted the cluster analysis on the first random half of the sample and replicated it
with the second half, and then compared the two solutions. We also examined whether the
clusters differed on external measures that were not part of the clustering but which were
expected to differ among clusters.
Second, a propensity scoring approach was used to reduce the biases inherent in nonrandom
assignment of participants to intervention and comparison conditions in the WCDVS
(Rosenbaum and Rubin 1984). The propensity score reduces the pretreatment differences
between the groups to a single score that appropriately summarizes those differences.
Weighting the outcomes by propensity score statistically balances the two groups with respect
to observed covariates.
Propensity scores are often estimated using logistic regression. McCaffrey et al. (2004)
compared two logistic regression methods of propensity score estimation to generalized
boosted modeling (GBM), an iterative algorithm that uses regression trees to develop
increasingly accurate estimates of the log-odds of assignment to treatment. They found that
relative to the logistic regression methods, GBM reduced prediction error, improved the
balance between groups on the means of the covariates, and resulted in estimated average
treatment effects with substantially smaller standard errors. Therefore, in the current analysis,
propensity scores were calculated using the GBM package developed by McCaffrey et al.,
along with R software, version 1.9.1 (R Development Core Team 2004). The propensity score
included 33 covariates in the following domains: demographic characteristics, traumatic events
history, ratings of physical and mental health, and previous mental health and substance abuse
treatment.
We assessed the success of the propensity scoring procedure in balancing the intervention and
comparison groups with respect to baseline covariates by comparing results of unweighted
intervention-versus-comparison t-tests on covariates and compared these to propensity score
weighted t-tests. Results indicated that the procedure was successful in balancing the
intervention and comparison groups on all selected baseline covariates. The unweighted tests
on covariates found that nine of the 33 variables were significantly different between
conditions. The propensity score weighted tests indicated that only two of these variables were
significantly different between conditions. Balance was also checked within each cluster,
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where 17% of the unweighted tests were significant, and 6% of weighted tests were significant
(close to what would be expected by chance alone).
We also compared effect sizes of covariate differences before and after propensity score
weighting as an additional check for balance between the conditions. The average effect size
of the unweighted tests was .06. Following weighting, the average effect size was .01,
indicating that the propensity score reduced the magnitude of difference between conditions.
Effect size analyses were also repeated within each cluster, with the same pattern of decreased
effect sizes after propensity score adjustment. (Details of these analyses are available from the
first author.)
Finally, propensity score weighted t-tests were used to examine the effects of the intervention
on the primary and secondary measures (PSS, ASI-D, ASI-A, and GSI) for each of the six
clusters. The dependent variable was change score from baseline to 12-months for all weighted
t-tests.
Results
Description of Empirically Derived Clusters
Figure 1 profiles the six groups based on mean z-scores computed for the sample as a whole
on PTSD symptoms and alcohol and drug use severity. Participants in Group 1: Low
Symptoms (n = 817) reported the lowest level of symptoms across PTSD, alcohol and drug use
severity. Group 2: Polysubstance Users (n = 162) contains participants who reported problems
primarily with drug and alcohol use. Group 3: PTSD/Alcohol (n = 272) is characterized by high
levels of PTSD symptoms and alcohol use problems. Group 4: PTSD/Drug (n = 488) is
characterized by high levels of PTSD symptoms and drug use problems. Group 5: Severe
Comorbid (n = 214) is characterized by high levels of all three PTSD, alcohol, and drug
problems. Group 6: PTSD (n = 672) is characterized primarily by high levels of PTSD
symptoms.
Characteristics of Subgroups
Demographic Characteristics—Table 1 presents a demographic profile of each of the six
subgroups. Using chi-square and ANOVA tests, we found significant relationships between
group membership and several demographic variables. In particular, groups differed on age F
(5, 2589) = 6.58, P < .001, current employment (X2 = 13.75, df = 5, P < .01), and whether they
had ever been homeless (X2 = 33.37, df = 5, P < .001). Groups also differed in the proportion
of Blacks (X2 = 41.59, df = 5, P < .001) and Whites (X2 = 32.85, df = 5, P < .001). Specifically,
Black women were disproportionately likely to appear in the Polysubstance group. White
women appeared disproportionately in the PTSD/Drug and the PTSD/Alcohol groups. Women
in the PTSD/Alcohol group were somewhat older than the rest of the women. Women in the
Low Symptom group and PTSD/Alcohol group were the most likely to be employed (22.1%),
while women in the PTSD group were least likely to be employed (15.2%). The greatest
proportion of women who were ever homeless was found among women in the Severe
Comorbid group (79.3%). There were no differences among the groups on marital status or
education.
Traumatic Experiences—Differences among groups were observed on several indicators
of traumatic experience (see Table 2). The proportion of women who reported childhood
physical, (X2 = 70.33, df = 5, P < .001) and sexual abuse (X2 = 86.58, df = 5, P < .001) varied
significantly by subgroup. The proportion who had experienced adult sexual (X2 = 74.69, df =
5, P < .001) and physical abuse (X2 = 50.35, df = 5, P < .001) also varied by subgroup.
Specifically, women in the Severe Comorbid group followed by the PTSD group had the highest
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rates of childhood and adult physical and sexual abuse experiences. The cumulative number
of lifetime experiences of interpersonal abuse also varied by subgroup F(5, 2583) = 61.99, P
< .001. Post hoc pairwise comparisons indicated that the Severe Comorbid and PTSD groups
reported the greatest number of lifetime abuse experiences.
Mental and Physical Health—Symptom severity related to depression F(5, 2617) =
181.39, P < .001, anxiety F(5, 2618) = 217.02, P < .001, paranoia F(5, 2617) = 129.25, P < .
001, psychoticism F(5, 2617) = 175.97, P < .001, and PTSD F(5, 2619) = 731.14, P < .001,
varied by symptom profile (see Table 3). Specifically, women in the Severe Comorbid group
reported the highest levels of psychoticism and women in the Severe Comorbid and PTSD
groups reported the highest levels of depression, anxiety, paranoia, and PTSD. Self-reported
age when first emotional or mental health problems began differed by symptom profile F(5,
2559) = 10.31, P < .001. Women in the Severe Comorbid, PTSD, and PTSD/Drug groups
reported a significantly younger age than women in the Polysubstance, Low Symptom, or
PTSD/Alcohol groups. Ratings for overall physical health differed by subgroup F(5, 2619) =
26.36, P < .001 and were poorest for women in the Severe Comorbid, PTSD, and PTSD/
Alcohol groups. The proportion of women reporting a serious physical illness differed by
profile (X2 = 35.99, df = 5, P < .001). Specifically, the PTSD group had the highest rate and
the Polysubstance and Low Symptom subgroups had the lowest rate.
Differential Intervention Effects by Cluster
PSS Symptoms—The results of propensity score weighted t-tests indicated significant
improvement for the PTSD/Drug t(365) = −2.53, P < .01, the Severe Cormorbid t(140) = −3.05,
P < .01, and the PTSD cluster t(480) = −2.63, P < .01. The adjusted mean change in PTSD
symptoms from baseline to 12 months is shown in Fig. 2 for each group. The largest effect was
found for the Severe Comorbid group, in which women in the intervention had an average
decrease of 14.1 points on the PSS, compared to a decrease of 8 points for the comparison
group (Cohen’s d effect size = .38), followed by the PTSD/Drug group (Cohen’s d effect size
= .27), and the PTSD group (Cohen’s d effect size = .24). To put these numbers in perspective,
a decrease of 14 points might indicate, for example, a change from a rating of “almost always”
to “once in a while” for seven of the 17 PTSD symptoms.
ASI-A Symptoms—The results of propensity score weighted t-tests indicated significant
improvement for the Polysubstance group t(122) = −2.72, P < .01. The mean change from
baseline to 12 months on the ASI-A for each cluster is shown in Fig. 3. The largest effect was
found for the Polysubstance cluster in which women in the intervention had an average decrease
of .59 on the 0–1 scale compared to .44 for the comparison group (Cohen’s d effect size = .
37).
ASI-D Symptoms—The results of propensity score-weighted t-tests indicated significant
improvement for the Polysubstance t(122) = −2.19, P < .05 and PTSD/Drug clusters t(374) =
−2.84, P < .01. The mean change from baseline to 12 months on the ASI-D for each subgroup
is shown in Fig. 4. The largest effect was found for the Polysubstance group in which
intervention women had an average decrease of .25 compared to .19 for the comparison
(Cohen’s d effect size = .29), followed by the PTSD/Drug group in which intervention women
had an average decrease of .27 compared to .24 for the comparison (Cohen’s d effect size = .
20).
GSI Symptoms—The results of propensity score-weighted t-tests indicated significant
improvement for the Polysubstance group t(122) = −2.37, P < .05, Severe Comorbid group t
(146) = −2.93, P < .01, and the PTSD group, t(489) = −2.36, P < .05. The mean change from
baseline to 12 months on the GSI for each subgroup is shown in Fig. 5. The largest effect was
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found for the Severe Comorbid cluster in which intervention women had an average decrease
of .82 compared to .41 for the comparison (Cohen’s d effect size = .36) followed by the
Polysubstance group in which intervention women had an average decrease of .21 compared
to an increase of .06 for the comparison (Cohen’s d effect size = .33).
Clinical Significance—We examined the clinical significance of the PTSD outcomes based
on cutoff scores as well as indicators of reliable change (see Table 4). The proportion of women
who were considered “cases” before treatment who would no longer be considered “cases”
following treatment was approximately 50% of all intervention participants among the four
PTSD clusters. Women who were above the cutoff at baseline (“cases”) yet below the cutoff
at the 12-month follow-up (“non-cases”) ranged from 37% to 47% among the four PTSD
clusters. The proportion who met the Jacobson and Truax (1991) criteria for reliable change
—which goes beyond the magnitude of the effect by also considering the reliability of the
measurement—ranged from 38% to 60% across the four PTSD clusters.
Discussion
The main finding emerging from the current study was that women with the most severe PTSD
and substance abuse presentation (Severe Comorbid Group) who received the integrated
intervention had the greatest amount of symptom reduction in PTSD symptoms relative to the
comparison condition, followed by women with the PTSD/Drug profile and those with the
PTSD profile. The PTSD effect size achieved by the Severe Comorbid subgroup (.38) is
considerably larger than that reported in the initial WCDVS outcomes paper (effect size = .16;
Morrissey, et al. 2005a, b) and consistent with effect sizes (.33–.61) found in studies of non-
exposure based PTSD interventions (Bisson et al. 2007).
These three subgroups of women represent a population of difficult to treat individuals and are
arguably the most in need of an integrated trauma-specific intervention. The fact that these
women obtained statistically significant and clinically meaningful change following the
integrated intervention is highly encouraging. Women in the PTSD/Alcohol profile were the
only subgroup characterized by PTSD symptoms whose PTSD outcomes were no better for
women in the integrated intervention than in the comparison condition (although both groups
achieved a moderate reduction of approximately 8 points on the PSS).
Our findings indicate that women in the WCDVS had a variety of outcomes associated with
interpersonal victimization. The findings regarding the heterogeneous symptom patterns are
consistent with studies examining rates of psychiatric disorder stemming from childhood and
adult victimization (Kendall-Tackett et al. 1993; Hanson et al. 2001), which indicate a full
range of outcomes associated with trauma—including no negative psychological outcomes
(Binder et al. 1996). The diversity of outcomes associated with trauma suggests that not all
persons with a trauma history and other mental health/substance abuse problems should need
the same intervention addressing traumatic experiences. In addition, the literature on
psychological interventions in the immediate aftermath of a traumatic event suggests that since
the majority of individuals do not develop psychological problems following trauma, trauma-
focused interventions broadly targeting a trauma-exposed group may disrupt the normal
recovery process and may even be harmful (Rauch et al. 2001; Gray and Litz 2005). As the
mental health and substance abuse fields have begun to recognize the role of traumatic
victimization in the needs of their clients, it is critical that a distinction between traumatic
victimization and trauma-related symptoms remain clear.
While the lack of treatment effect for the PTSD/Alcohol group is somewhat surprising, this
finding is in part consistent with literature examining differences in women with PTSD who
abuse drugs versus alcohol (Back et al. 2003; Saladin et al. 1995). The extant literature suggests
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that women with PTSD who abuse alcohol are likely to be older, have chronic PTSD, and have
higher levels of avoidance and arousal. This is exactly what was found in the current study.
Although chronicity was not addressed in the WCDVS, women with PTSD/Alcohol were older
than any other profile and had significantly higher avoidance and arousal symptoms than
women with the PTSD/Drug profile. In light of this, the finding of no improvement for women
with PTSD/Alcohol may speak to a more treatment-resistant form of PTSD. Future research
is needed to further explore these differential patterns of comorbidity.
In order to address concerns that symptoms other than PTSD are important treatment targets,
we also looked at the GSI as an indicator of treatment outcome. Similar to their PTSD outcomes,
the subgroups with the highest levels of PTSD symptoms (Severe Comorbid and PTSD)
improved significantly on the GSI. The two other clusters characterized by PTSD and substance
abuse (PTSD/Alcohol, PTSD/Drug) did not improve significantly on the GSI relative to the
comparison condition. One possible explanation is that it takes greater reductions in PTSD
symptoms—of the magnitude experienced by the Severe Comorbid and PTSD clusters—to
impact symptoms that may be secondary to PTSD.
Contrary to hypotheses, we found overall little differential improvement in substance abuse
outcomes for the three PTSD groups with comorbid drug or alcohol problems. It is possible
that the duration and/or intensity of the substance abuse component of the intervention was
insufficient for these dually disordered groups. More research is needed on interventions that
simultaneously address PTSD and substance abuse to determine the optimal balance of
efficiency and effectiveness.
One benefit of analyzing treatment outcome by subgroup is that we were able to examine the
impact of the integrated intervention in the two subgroups without significant levels of current
PTSD symptoms (Group 1: Low Symptom and Group 2: Polysubstance). Of equal importance
to the above findings is that there was no positive effect of the integrated intervention for
women in the Low Symptom cluster on either PTSD symptoms or other mental health domains
frequently mentioned as trauma-related problems. In contrast, women in the Polysubstance
cluster did have significantly greater improvement on the alcohol and drug measures. These
women also improved on the GSI relative to women in the comparison condition. However,
the magnitude of change was small, corresponding to a change of 2 T-score points.
While some form of mental health service (e.g., careful assessment/PTSD screening) may be
appropriate for all trauma victims, and other specific interventions may be appropriate for
many trauma victims (e.g., safety planning, assertiveness skills), the current findings suggest
that integrated trauma-specific interventions are not necessarily helpful for women with any
mental health and substance abuse presentation simply on the basis of their history of
interpersonal abuse. As in other areas of life, one size does not fit all; trauma interventions
must be tailored to the presenting problems and experiences of each individual. Further,
integrated interventions are demanding, time consuming, and costly—not only for the women
recipients, but for clinicians and payers as well (Domino et al. 2005a, b). Public mental health
systems in the U.S. have constrained resources and individuals with PTSD are particularly
highly underserved (Cusack et al. 2006; Mueser et al. 1998; Switzer et al. 1999). Therefore,
the scant resources available in mental health systems should be prioritized for those clearly
in need of intervention.
Limitations
The findings are based on secondary analyses that are largely exploratory and hypothesis
generating. While k-means cluster analysis is a useful technique for describing subgroups, it
is an exploratory technique that does not yield definitive results. Women in the study were
recruited to take part in the intervention. Therefore, the results may not be representative of
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the population of women with co-occurring disorders who are victims of interpersonal abuse
and high-end users of substance abuse and mental health services. However, the large sample
size, range of urban/rural sites, and diversity of service settings in the study increase the
confidence that the women in the WCDVS are representative of this group. On the other hand,
a drawback of analyzing large samples is that the analyses may produce statistically significant
results that have little clinical significance. Based on indicators of clinical significance in the
present study, our findings are indicative of meaningful effects. Although the use of propensity
score adjustment can be a useful method for reducing bias associated with non-random
assignment to conditions, the propensity score incorporates only measured covariates and
therefore cannot account for bias resulting from unmeasured variables. To the extent that the
measured covariates in this study do not capture all pretreatment differences between the two
conditions, bias may still exist. Further research with randomized designs is needed for more
rigorous tests of the relationship between trauma symptom profiles and differential responses
to integrated interventions.
Conclusions
Targeting trauma-related interventions is essential for optimal benefits. Clinicians working
with women victims of interpersonal violence should conduct careful assessments of current
symptoms to identify the need for intervention. We suggest that integrated trauma-related
interventions should be reserved for women who are most in need and may be expected to
benefit from such interventions. Our findings indicate that these are women with active PTSD
symptoms. Women with other characteristics such as polysubstance use without PTSD may
obtain some benefit from such an intervention, but choosing interventions specifically
addressing their presenting symptoms may have more positive results.
Acknowledgments
This work was supported in part by MH019117 from the National Institute of Mental Health and the Guidance for
Applicants (GFA) No. TI 00-003 entitled Cooperative Agreement to Study Women with Alcohol, Drug Abuse and
Mental Health (ADM) Disorders who have Histories of Violence: Phase II from the Department of Health and Human
Services, Public Health Service, Substance Abuse and Mental Health Administration’s three centers: Center for
Substance Abuse Treatment, Center for Mental Health Services, and Center for Substance Abuse Prevention (March,
2000). Portions of this paper were previously presented at the annual meeting of the International Society for Traumatic
Stress Studies in Hollywood (November, 2006).
References
Back SE, Sonne SC, Killeen T, Dansky BS, Brady KT. Comparative profiles of women with PTSD and
comorbid cocaine or alcohol dependence. The American Journal of Drug and Alcohol Abuse 2003;29
(1):169–189. [PubMed: 12731687]
Beck JC, van der Kolk BA. Reports of childhood incest and current behavior of chronically hospitalized
psychotic women. American Journal of Psychiatry 1987;144:1474–1476. [PubMed: 3674230]
Becker MA, Noether CD, Larson MJ, Gatz M, Brown V, Heckman JP, et al. Characteristics of women
engaged in treatment for trauma and co-occurring disorders: Findings from a multisite study. Journal
of Community Psychology 2005;33(4):429–443.
Binder RL, McNiel DE, Goldstone RL. Is adaptive coping possible for adult survivors of childhood sexual
abuse? Psychiatric Services 1996;47:186–188. [PubMed: 8825257]
Bisson JI, Ehlers A, Mattews R, Pilling S, Richards D, Turner S. Psychological treatments for chronic
post-traumatic stress disorder: Systematic review and meta-analysis. British Journal of Psychiatry
2007;190:97–104. [PubMed: 17267924]
Brady KT, Back SE, Coffey SF. Substance abuse and posttraumatic stress disorder. Current Directions
in Psychological Science 2004;13(5):206–209.
Cusack et al. Page 10













Breslau N, Davis GC, Peterson EL, Schultz LR. A second look at comorbidity in victims of trauma: The
posttraumatic stress disorder-major depression connection. Biological Psychiatry 2000;48:902–909.
[PubMed: 11074228]
Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic
stress disorder in the community: The 1996 Detroit area survey of trauma. Archives of General
Psychiatry 1998;55(7):626–632. [PubMed: 9672053]
Briere J, Woo R, McRae B, Foltz J, Sitzman R. Lifetime victimization history, demographics, and clinical
status in female psychiatric emergency room patients. Journal of Nervous and Mental Disease
1997;185:95–101. [PubMed: 9048701]
Carmen E, Rieker PP, Mills T. Victims of violence and psychiatric illness. American Journal of Psychiatry
1984;141:378–383. [PubMed: 6703102]
Cascardi M, Mueser KT, DeGirolomo J, Murrin M. Physical aggression against psychiatric inpatients by
family members and partners: A descriptive study. Psychiatric Services 1996;47:531–533. [PubMed:
8740498]
Chilcoat HD, Breslau N. Posttraumatic stress disorder and drug disorders: Testing causal pathways.
Archives of General Psychiatry 1998;55:913–917. [PubMed: 9783562]
Cocozza JJ, Jackson EW, Hennigan K, Morrissey JP, Reed BG, Fallot R, et al. Outcomes for women
with co-occurring disorders and trauma: Program-level effects. Journal of Substance Abuse
Treatment 2005;28:109–119. [PubMed: 15780540]
Craine LS, Henson CE, Colliver JA, MacLean DG. Prevalence of a history of sexual abuse among female
psychiatric patients in a state hospital system. Hospital and Community Psychiatry 1988;39:300–
304. [PubMed: 3356438]
Cusack KJ, Grubaugh AL, Knapp R, Frueh BC. Trauma and PTSD in public mental health consumers
with serious mental illness. Community Mental Health Journal 2006;42:487–500. [PubMed:
16868841]
Derogatis, L. A brief form of the SCL-90-R: A self-report symptom inventory designed to measure
psychological stress: Brief Symptom Inventory (BSI). Minneapolis: National Computer Systems;
1993.
Domino ME, Morrissey JP, Chung S, Huntington N, Larson MJ, Russel LA. Service use and costs for
women with co-occurring mental and substance use disorders and a history of violence. Psychiatric
Services 2005a;56:1223–1232. [PubMed: 16215187]
Domino M, Morrissey JP, Nadlicki-Patterson T, Chung S. Service costs for women with co-occurring
disorders and trauma. Journal of Substance Abuse Treatment 2005b;28(2):135–143. [PubMed:
15780542]
Drake RE, Mueser KT. Managing comorbid schizophrenia and substance abuse. Current Psychiatry
Reports 2001;3:418–422. [PubMed: 11559480]
Elhai JD, North TC, Frueh BC. Health service use predictors among trauma survivors: A critical review.
Psychological Services 2005;2:3–19.
Fallot RD, Harris M. The trauma recovery and empowerment model (TREM): Conceptual and practical
issues in a group intervention for women. Community Mental Health Journal 2002;38(6):475–485.
[PubMed: 12474935]
Foa, EB.; Keane, TM.; Friedman, MJ. Effective treatments for PTSD: Practice guidelines from the
international society for traumatic stress studies. New York: Guilford; 2000.
Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing
post-traumatic stress disorder. Journal of Traumatic Stress 1993;6:459–473.
Frueh BC, Cusack KJ, Hiers TG, Monogan S, Cousins VC, Cavenaugh SD. Improving public mental
health services for trauma victims in South Carolina. Psychiatric Services 2001;52(6):812–814.
[PubMed: 11376230]
Goodman LA, Dutton MA, Harris M. Physical and sexual assault prevalence among episodically
homeless, seriously mentally ill women. Violence and Victims 1995;11:159–174. [PubMed:
8933711]
Gray MJ, Litz BT. Behavioral interventions for recent trauma: Empirically informed practice guidelines.
Behavior Modification 2005;29(1):189–215. [PubMed: 15557483]
Cusack et al. Page 11













Hair, JF., Jr; Anderson, RE.; Tatham, RL.; Black, WC. Multivariate data analysis. Upper Saddle River,
NJ: Prentice-Hall; 1998.
Hanson RF, Saunders B, Kilpatrick D, Resnick H, Crouch JA, Duncan R. Impact of childhood rape and
aggravated assault on adult mental health. American Journal of Orthopsychiatry 2001;71(1):108–
119. [PubMed: 11271710]
Hartigan, JA. Clustering algorithms. New York: Wiley; 1975.
Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress
disorder: A review of the literature. American Journal of Psychiatry 2001;158:1184–1190. [PubMed:
11481147]
Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in
psychotherapy research. Journal of Consulting and Clinical Psychology 1991;59(1):12–19.
[PubMed: 2002127]
Jennings A. Models for developing trauma-informed behavioral-health systems and trauma-specific
services. National Association of Mental Health Program Directors, National Technical Assistance
Center for State Mental Health Planning. 2004
Kendall-Tackett KA, Williams LM, Finkelhor D. Impact of sexual abuse on children: A review and
synthesis of recent empirical studies. Psychological Bulletin 1993;13:164–180. [PubMed: 8426874]
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National
Comorbidity Study. Archives of General Psychiatry 1995;52(12):1048–1060. [PubMed: 7492257]
Kilpatrick, DG.; Resnick, HS.; Saunders, BE.; Best, CL. Rape, other violence against women, and
posttraumatic stress disorder. In: Dohrenwend, BP., editor. Adversity, Stress, and Psychopathology.
New York: Oxford Press; 1998.
McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for
evaluating causal effects in observational studies. Psychological Methods 2004;9(4):403–425.
[PubMed: 15598095]
McHugo GJ, Caspi Y, Kammerer N, Mazelis R, Jackson EW, Russell L, et al. The assessment of trauma
history in women with co-occurring substance abuse and mental disorders and a history of
interpersonal violence. Journal of Behavioral Health Services & Research 2005a;32(2):113–127.
[PubMed: 15834262]
McHugo GJ, Kammerer N, Jackson EW, Markoff LS, Gatz M, Larson MJ, et al. Women, co-occurring
disorders, and violence study: Evaluation design and study population. Journal of Substance Abuse
Treatment 2005b;28(2):91–107. [PubMed: 15780539]
McLellan A, Luborsky L, O’Brien CP, Woody G. An improved diagnostic evaluation instrument for
substance abuse patients: The addiction severity index. Journal of Nervous and Mental Disease
1980;168:26–33. [PubMed: 7351540]
Morrissey JP, Ellis AR, Gatz M, Amaro H, Reed BG, Savage A, et al. Outcomes for women with co-
occurring disorders and trauma: Program and person-level effects. Journal of Substance Abuse
Treatment 2005a;28(2):121–134. [PubMed: 15780541]
Morrissey JP, Jackson EW, Ellis AR, Amaro H, Brown VB, Najavits LM. Twelve-month outcomes of
trauma-informed interventions for women with co-occurring disorders. Psychiatric Services 2005b;
56(10):1213–1222. [PubMed: 16215186]
Muenzenmaier K, Meyer I, Struening E, Ferber J. Childhood abuse and neglect among women outpatients
with chronic mental illness. Hospital and Community Psychiatry 1993;44:666–670. [PubMed:
8192738]
Mueser KT, Goodman LB, Trumbetta SL, Rosenberg SD, Osher FC, Vidaver R, et al. Trauma and
posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology
1998;66:493–499. [PubMed: 9642887]
Mueser, KT.; Noordsy, DL.; Drake, RE.; Fox, L. Integrated treatment for dual disorders. New York:
Guilford Press; 2003.
Mueser KT, Rosenberg SD, Goodman LA, Trumbetta SL. Trauma, PTSD, and the course of severe mental
illness: An interactive model. Schizophrenia Research 2002;53:123–143. [PubMed: 11728845]
Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder
in women: A research review. American Journal of Addictions 1997;6:273–283.
Cusack et al. Page 12













Pimlott-Kubiak S, Cortina LM. Gender, victimization, and outcomes: Reconceptualizing risk. Journal of
Consulting and Clinical Psychology 2003;71(3):528–539. [PubMed: 12795576]
R Development Core Team. R: A language and environment for statistical computing. Vienna: R
Foundation for Statistical Computing; 2004.
Rauch SA, Hembree EA, Foa EB. Acute psychosocial preventive interventions for posttraumatic stress
disorder. Advances in Mind-Body Medicine 2001;17(3):187–190. [PubMed: 11572846]
Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the
propensity score. Journal of the American Statistical Association 1984;79:516–524.
Saladin ME, Brady KT, Kilpatrick DG. Understanding comorbidity between PTSD and substance use
disorders: Two preliminary investigations. Addictive Behaviors 1995;20(5):643–655. [PubMed:
8712061]
Surrey J, Swett C Jr, Michaels A, Levin S. Reported history of physical and sexual abuse and severity of
symptomatology in women psychiatric outpatients. American Journal of Orthopsychiatry
1990;60:412–417. [PubMed: 2382692]
Switzer GE, Dew MA, Thompson K, Goycoolca JM, Derricott T, Mullins SD. Posttraumatic stress
disorder and service utilization among urban mental health center clients. Journal of Traumatic Stress
1999;12:25–39. [PubMed: 10027140]
Tjaden P, Thoennes N. Prevalence and consequences of male-to-female and female-to-male intimate
partner violence as measured by the National violence against women survey. Violence Against
Women 2000;6(2):142–161.
U.S. Department of Health and Human Services. Mental health. A Report of the Surgeon General. 1999
Wolfe, J.; Kimerling, R. Gender issues in the assessment of posttraumatic stress disorder. In: Wilson,
JP.; Keane, TM., editors. Assessing psychological trauma and PTSD. New York: Guilford; 1997. p.
192-238.
Cusack et al. Page 13














Profiles of mean symptom levels for each group. Note: PTSD severity is measured with the
PSS; Drug use severity is measured with the ASI-D; Alcohol use severity is measured with the
ASI-A
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Propensity-weighted PTSD symptom change by cluster and study condition. Cluster 1 = Low
symptom group; Cluster 2 = Substance abuse group; Cluster 3 = PTSD/Alcohol group; Cluster
4 = PTSD/Drug group; Cluster 5 = Severe comorbid group; Cluster 6 = PTSD group. * Higher
scores correspond to greater improvement
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Propensity-weighted change in alcohol use severity by cluster and study condition. Cluster 1
= Low symptom group; Cluster 2 = Substance abuse group; Cluster 3 = PTSD/Alcohol group;
Cluster 4 = PTSD/Drug group; Cluster 5 = Severe comorbid group; Cluster 6 = PTSD group.
* Higher scores correspond to greater improvement
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Propensity-weighted change in drug use severity by cluster and study condition. Cluster 1 =
Low symptom group; Cluster 2 = Substance abuse group; Cluster 3 = PTSD/Alcohol group;
Cluster 4 = PTSD/Drug group; Cluster 5 = Severe comorbid group; Cluster 6 = PTSD group.
* Higher scores correspond to greater improvement
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Propensity-weighted change in GSI by cluster and study condition. Cluster 1 = Low symptom
group; Cluster 2 = Substance abuse group; Cluster 3 = PTSD/Alcohol group; Cluster 4 = PTSD/
Drug group; Cluster 5 = Severe comorbid group; Cluster 6 = PTSD group. * Higher scores
correspond to greater improvement
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